Skip to main content
INVAMED
HomeINVAblogStent Thrombosis and Antiplatelet Therapy: FAQ
Coronary Artery Disease & Cardiac InterventionsApril 16, 2025INVAMED Medical Affairs

Stent Thrombosis and Antiplatelet Therapy: FAQ

Common questions about stent thrombosis and why physicians prescribe antiplatelet therapy after coronary stenting, explained for patients.

Stent thrombosis is a term patients often encounter after coronary stent placement, and understanding it can help explain why physicians place such strong emphasis on taking prescribed antiplatelet medication exactly as directed. This FAQ-style article addresses common patient questions in plain language. It is educational in nature and does not replace guidance from the cardiologist or care team managing an individual's treatment.

What Is Stent Thrombosis?

Stent thrombosis refers to the sudden formation of a blood clot at the site of a previously placed coronary stent. Unlike in-stent restenosis, which develops gradually over months due to tissue growth, stent thrombosis can occur abruptly and is considered a serious event because it can suddenly and significantly reduce blood flow through the treated artery.

  • It can occur early (within days), late (within the first year), or, less commonly, very late (beyond one year) after stent placement.
  • Contributing factors may include how well the stent is apposed to the vessel wall, whether antiplatelet medication is being taken as prescribed, and individual patient biology.
  • Because it can present suddenly, any new or severe chest discomfort after a stent procedure should be treated as a potential medical emergency.

Why Do Physicians Prescribe Antiplatelet Therapy After Stenting?

After a stent is placed, the treated segment of the artery undergoes a natural healing process during which the stent surface can be more susceptible to clot formation until it is fully incorporated into the vessel wall. Antiplatelet medications work by reducing the tendency of platelets to clump together and form clots.

Physicians commonly prescribe a combination of two antiplatelet medications, often referred to as dual antiplatelet therapy (DAPT), for a defined period after stenting. The specific medications and duration are determined by the cardiologist based on the type of stent used, the clinical scenario, and the individual patient's bleeding and clotting risk profile.

Frequently Asked Questions

Can I stop taking my antiplatelet medication early if I feel fine?

No patient should stop or adjust antiplatelet medication without first speaking directly with the prescribing physician. Stopping these medications prematurely, even when feeling well, has been associated with an increased risk of stent thrombosis. Any concerns about side effects, upcoming procedures, or medication changes should be discussed with the cardiologist before making adjustments.

How long will I need to take antiplatelet medication after a stent?

Duration varies by individual case and is determined by the treating cardiologist, taking into account the type of stent placed, the clinical indication for the procedure, and the patient's bleeding risk. Some patients may be prescribed therapy for a defined number of months, while others may have different recommendations. Only the prescribing physician can provide guidance specific to an individual situation.

What should I do if I think I am experiencing stent thrombosis?

Symptoms suggestive of stent thrombosis may resemble a heart attack, including sudden or severe chest pain, shortness of breath, or sweating. This should be treated as a medical emergency, and patients experiencing these symptoms should seek immediate emergency care rather than waiting to contact their regular physician's office.

Why This Requires Physician Guidance

The balance between preventing stent thrombosis and managing bleeding risk from antiplatelet medication is a nuanced clinical decision that depends on many individual factors, including other medications, planned procedures or surgeries, and overall health status. This is why patients are strongly encouraged to maintain open communication with their cardiologist, attend follow-up appointments, and never make independent changes to prescribed antiplatelet regimens.

Related INVAMED Resources


Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.

Reviewed by: INVAMED Medical Affairs

This content is prepared for educational purposes for healthcare professionals and does not constitute medical advice. Always consult clinical guidelines and product instructions for use.

stent thrombosisantiplatelet therapy after stentdual antiplatelet therapyblood clot in stentclopidogrel after stent